Cogent Communications Holdings, Inc. (“Cogent”) (NASDAQ: CCOI) will host a conference call at 8:30 a.m. (ET) on November 6, 2025 to present Cogent's operating results for the third quarter of 2025 and answer questions. Cogent will issue a press release announcing the operating results at 7:00 a.m. (ET) on November 6, 2025. https://mma.prnewswire.com/media/94565/cogent_communications_logo.jpg Participation is […]
(NASDAQ:SCWO), Executed PFAS Destruction of Multiple Concentrated Waste Streams at Commercial TSDF using AirSCWO(TM) 6 System Final Report to be Released by Q1 2026 DURHAM, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology and services for the industrial, municipal, and
(NASDAQ:FBIO),(NASDAQ:FBIOP), MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys Therapeutics, Inc. (“Crystalys”), in which Urica maintains an equity position, dosed first patients in its two randomized, double-blind, multicenter global Phase 3 trials, the RUBY study (NCT07089875) and
In this free webinar, learn how to reduce delays and improve efficiency in Chemistry, Manufacturing and Controls (CMC) development. The featured speaker will discuss and understand common obstacles, enabling teams to address them proactively and strengthen outcomes. Attendees will discover how leveraging digital platforms and structured processes can significantly reduce errors and enable more informed
— Real-world evidence (RWE) data estimate 19.8% relative vaccine effectiveness (rVE) of cell-based quadrivalent influenza vaccines (QIVc) versus standard egg-based quadrivalent vaccines (QIVe) in the prevention of test-confirmed influenza during the 2023/24 U.S. season for populations six months to 64 years.1 — Consistent rVE results were observed for pediatric, adult, outpatient and high-risk subgroups.1 —
Krell Technologies, a leading manufacturer of precision polishing and inspection systems for photonic components, has been recognized as Innovator of the Year at the 2025 New Jersey Manufacturing Awards, hosted by the New Jersey Manufacturing Extension Program (NJMEP). The annual event brought together thousands of manufacturers, business leaders, and policymakers from across the state to
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the Thyroid Microwave Ablation Workshop held at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia. https://mma.prnewswire.com/media/2801159/Baird_malaysia.jpg The immersive two-day workshop, held from October 1-2, 2025, brought together leading
NetworkNewsWire Editorial Coverage Artificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer detection, where early diagnosis can mean the difference between life and death, AI-enhanced modalities present a chance to leap beyond the limits of mammography,tomosynthesis, and MRI. Globally, breast cancer remains one
AudioEye, Inc.(Nasdaq: AEYE) (“AudioEye” or the “Company”), the industry-leading digital accessibility company, will hold a conference call on Tuesday, November 4, 2025 at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2025. Financial results will be issued in a press release prior to the call. https://mma.prnewswire.com/media/1470477/AudioEye_v3_Logo.jpg AudioEye
374Water Completes Commercial-Scale Field Demonstration for DoD ESTCP/DIU Project GlobeNewswire October 21, 2025 Executed PFAS Destruction of Multiple Concentrated Waste Streams at Commercial TSDF using AirSCWO(TM) 6 System Final Report to be Released by Q1 2026 DURHAM, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader